Page 39 - Global Growth Pharmaceuticals & Biotech Stocks

UPDATED Sep 08, 2025

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,050 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
SPRB
Spruce Biosciences
US$9.0028.6%-73.9%US$5.1mUS$10.00PS3.9xE6.2%n/a
4553
Towa Pharmaceutical
JP¥3,035.001.6%3.9%JP¥149.4bJP¥3,920.00PE9.3xE6.1%2.6%
CATX
Perspective Therapeutics
US$3.432.1%-78.0%US$256.9mUS$13.96PS206.3xE6.1%n/a
4530
Hisamitsu Pharmaceutical
JP¥4,339.000.9%7.4%JP¥308.6bJP¥4,350.00PE15.8xE6.0%2.1%
TRVI
Trevi Therapeutics
US$7.604.5%141.3%US$925.5mUS$20.60PB4.7xE6.0%n/a
HLN
Haleon
UK£3.59-0.5%-8.7%UK£32.1bUK£4.14PE21.1xE6.0%1.9%
AURA
Aura Biosciences
US$6.473.4%-19.5%US$402.5mUS$21.00PB2.3xE5.8%n/a
BMY
Bristol-Myers Squibb
US$46.72-1.0%-3.7%US$96.0bUS$53.00PE18.8xE5.8%5.3%
ENLV
Enlivex Therapeutics
US$1.04-1.0%-13.3%US$25.3mUS$10.00PB1.3xE5.5%n/a
600267
Zhejiang Hisun Pharmaceutical
CN¥10.46-1.7%45.9%CN¥12.2bCN¥7.00PE26.3xE5.5%2.0%
TNGX
Tango Therapeutics
US$6.811.5%-25.7%US$772.1mUS$10.88PS31.2xE5.2%n/a
4880
CellSource
JP¥620.003.3%-55.6%JP¥12.3bJP¥880.00PE19.7xE5.1%0.8%
CPH
Cipher Pharmaceuticals
CA$16.795.4%-6.5%CA$405.6mCA$17.90PE25.4xE5.0%n/a
INBX
Inhibrx Biosciences
US$29.103.2%91.4%US$408.2mn/aPS301.1xE5.0%n/a
CNTB
Connect Biopharma Holdings
US$1.80-14.7%41.7%US$100.3mUS$6.83PS51xE4.9%n/a
AIP
Adcock Ingram Holdings
R72.00-0.3%11.2%R10.6bR75.00PE12.3xE4.8%3.9%
2877
China Shineway Pharmaceutical Group
HK$8.741.9%8.4%HK$6.6bHK$8.54PE7.3xE4.8%5.9%
AMPH
Amphastar Pharmaceuticals
US$29.26-4.4%-34.3%US$1.4bUS$32.67PE10.1xE4.7%n/a
ELTX
Elicio Therapeutics
US$11.7011.1%191.8%US$187.4mUS$12.50PB104.1xE4.7%n/a
BIAF
bioAffinity Technologies
US$0.241.2%-82.4%US$6.7mn/aPE-0.6xE4.6%n/a
500257
Lupin
₹1,958.953.7%-11.9%₹894.8b₹2,224.81PE24.2xE4.5%0.6%
ALKEM
Alkem Laboratories
₹5,336.001.7%-15.5%₹638.0b₹5,534.81PE27.9xE4.5%0.8%
SERA
Sera Prognostics
US$3.17-1.9%-56.6%US$127.1mn/aPS1117.2xE4.4%n/a
RPRX
Royalty Pharma
US$35.80-0.5%27.4%US$21.0bUS$44.86PE15.2xE4.4%2.5%
Page 39 of 128